{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:25:44Z","timestamp":1787754344529,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"\n Background:<\/jats:title>\n Understanding the causative microorganisms and initiating appropriate empirical antibiotics early are important in the management of knee periprosthetic joint infections (PJIs). The aim of this study was to identify trends in PJI microorganisms and antibiotic resistance profiles over 24 years to guide empirical antibiotic selection.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n This study included 487 first-episode PJIs identified between 2000 and 2023 following primary total knee arthroplasty (TKA) at 3 large tertiary hospitals. PJIs were classified using the Tsukayama classification, which is based on the timing from the primary TKA and the source of infection. Multivariable logistic regression was used to analyze risk factors for polymicrobial and resistant infections.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n A total of 487 PJI cases with 608 culture specimens were identified. The mean patient age (and standard deviation) was 70 \u00b1 11 years, with 65% male patients and 35% female patients. All ethnicity data were self-reported. Of the patients in this study, 57% were New Zealand European, 14% were other European, 14% were Pacific Islander, 10% were New Zealand M\u0101ori, and 6% were Asian. The most common pathogen for PJIs was\n Staphylococcus aureus<\/jats:italic>\n . The proportion of resistant cases (19% to 24%) was consistent across the 24-year period. A prosthesis in situ for <1 year was found to be the most important risk factor for polymicrobial infections (11 times more likely) and resistant infections (3 times more likely). Flucloxacillin monotherapy covered 45% of early PJI cases, 57% of chronic PJI cases, and 79% of late hematogenous cases. In comparison, vancomycin monotherapy provided coverage of \u226578% across all 3 PJI classes, and adding a gram-negative antibiotic such as gentamicin or cotrimoxazole increased coverage to >90%.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n Despite the known emergence of resistant organisms in health-care settings, the primary causative microorganisms remained the same in knee PJIs, with no notable increase in resistant cases, over 24 years. Based on the findings of this study, vancomycin with gram-negative coverage is recommended as the empirical treatment of choice in early PJIs, and beta-lactams, such as flucloxacillin and a first-generation cephalosporin (e.g., cefazolin), were found to still be effective for late hematogenous PJIs. For septic PJI, dual therapy with vancomycin and a gram-negative agent is recommended, regardless of infection timing.<\/jats:p>\n <\/jats:sec>\n \n Level of Evidence:<\/jats:title>\n \n Prognostic\n Level III<\/jats:underline>\n . See Instructions for Authors for a complete description of levels of evidence.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.2106\/jbjs.25.00541","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T19:05:40Z","timestamp":1767639940000},"page":"1008-1014","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Microbial Resistance Patterns in Periprosthetic Joint Infection of the Knee"],"prefix":"10.2106","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2867-2186","authenticated-orcid":false,"given":"Ruikang","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, North Shore Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1704-120X","authenticated-orcid":false,"given":"Mei Lin","family":"Tay","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, North Shore Hospital, Auckland, New Zealand"},{"name":"Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8341-2945","authenticated-orcid":false,"given":"Katy","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, North Shore Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, North Shore Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0286-8052","authenticated-orcid":false,"given":"Simon W.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, North Shore Hospital, Auckland, New Zealand"},{"name":"Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"9","key":"bib1-20260730","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1007\/s11999-017-5396-4","article-title":"Periprosthetic joint infection is the main cause of failure for modern knee arthroplasty: an analysis of 11,134 knees","volume":"475","author":"Koh","year":"2017","journal-title":"Clin Orthop Relat Res."},{"issue":"12","key":"bib2-20260730","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/cid\/cix227","article-title":"The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: the results of a large multicenter study","volume":"64","author":"Lora-Tamayo","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"6","key":"bib3-20260730","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3855\/jidc.11013","article-title":"Risk factors for periprosthetic joint infection after primary artificial hip and knee joint replacements","volume":"14","author":"Guo","year":"2020","journal-title":"J Infect Dev Ctries."},{"issue":"5","key":"bib4-20260730","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00264-013-2265-y","article-title":"Periprosthetic joint infection\u2014effect on quality of life","volume":"38","author":"Helwig","year":"2014","journal-title":"Int Orthop."},{"issue":"12","key":"bib5-20260730","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1016\/j.arth.2018.08.021","article-title":"Mortality during total knee periprosthetic joint infection","volume":"33","author":"Lum","year":"2018","journal-title":"J Arthroplasty."},{"issue":"6","key":"bib6-20260730","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2106\/00004623-198971060-00005","article-title":"Two-stage reconstruction of a total hip arthroplasty because of infection","volume":"71","author":"McDonald","year":"1989","journal-title":"J Bone Joint Surg Am."},{"issue":"10","key":"bib7-20260730","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1469-0691.2006.01523.x","article-title":"Treatment of bone and joint infections caused by gram-negative bacilli with a cefepime-fluoroquinolone combination","volume":"12","author":"Legout","year":"2006","journal-title":"Clin Microbiol Infect."},{"issue":"2","key":"bib8-20260730","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s15010-002-3079-9","article-title":"Management of infection associated with prosthetic joints","volume":"31","author":"Zimmerli","year":"2003","journal-title":"Infection."},{"issue":"6","key":"bib9-20260730","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.arth.2019.01.066","article-title":"Failed debridement and implant retention does not compromise the success of subsequent staged revision in infected total knee arthroplasty","volume":"34","author":"Kim","year":"2019","journal-title":"J Arthroplasty."},{"issue":"11","key":"bib10-20260730","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1007\/s11999-011-2102-9","article-title":"New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society","volume":"469","author":"Parvizi","year":"2011","journal-title":"Clin Orthop Relat Res."},{"issue":"6","key":"bib11-20260730","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1469-0691.2006.01454.x","article-title":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing","volume":"12","author":"Kahlmeter","year":"2006","journal-title":"Clin Microbiol Infect."},{"issue":"2","key":"bib12-20260730","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/imj.15677","article-title":"Proposed empiric antibiotic therapy for prosthetic joint infections: an analysis of the Prosthetic Joint Infection in Australia and New Zealand, Observational (PIANO) cohort","volume":"52","author":"Davis","year":"2022","journal-title":"Intern Med J."},{"issue":"9","key":"bib13-20260730","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.arth.2022.04.014","article-title":"Differing microorganism profile in early and late prosthetic joint infections following primary total knee arthroplasty - implications for empiric antibiotic treatment","volume":"37","author":"Kim","year":"2022","journal-title":"J Arthroplasty."},{"issue":"6","key":"bib14-20260730","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2106\/00004623-200606000-00009","article-title":"Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites","volume":"88","author":"Fulkerson","year":"2006","journal-title":"J Bone Joint Surg Am."},{"issue":"8","key":"bib15-20260730","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"issue":"5","key":"bib16-20260730","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-0033-1364102","article-title":"Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the United States","volume":"27","author":"Aggarwal","year":"2014","journal-title":"J Knee Surg."},{"issue":"3","key":"bib17-20260730","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.diagmicrobio.2019.01.006","article-title":"Microbiology of polymicrobial prosthetic joint infection","volume":"94","author":"Flurin","year":"2019","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"7","key":"bib18-20260730","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3390\/diagnostics12071654","article-title":"Microbiological profiles of patients with periprosthetic joint infection of the hip or knee","volume":"12","author":"Fr\u00f6schen","year":"2022","journal-title":"Diagnostics (Basel)."},{"issue":"2","key":"bib19-20260730","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12306-020-00638-y","article-title":"Epidemiology and microbiology of prosthetic joint infections: a nine-year, single-center experience in Pavia, Northern Italy","volume":"105","author":"Mussa","year":"2021","journal-title":"Musculoskelet Surg."},{"issue":"12","key":"bib20-20260730","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/ans.13720","article-title":"Antibiotic resistance in early periprosthetic joint infection","volume":"86","author":"Ravi","year":"2016","journal-title":"ANZ J Surg."},{"issue":"4","key":"bib21-20260730","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jinf.2017.12.016","article-title":"Analysis of postoperative and hematogenous prosthetic joint-infection microbiological patterns in a large cohort","volume":"76","author":"Zeller","year":"2018","journal-title":"J Infect."},{"issue":"6","key":"bib22-20260730","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.arth.2011.03.044","article-title":"Prosthetic joint infection caused by gram-negative organisms","volume":"26","author":"Zmistowski","year":"2011","journal-title":"J Arthroplasty."},{"issue":"7","key":"bib23-20260730","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1086\/605593","article-title":"Gram-negative prosthetic joint infections: risk factors and outcome of treatment","volume":"49","author":"Hsieh","year":"2009","journal-title":"Clin Infect Dis."},{"issue":"3","key":"bib24-20260730","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.arth.2019.09.044","article-title":"Treatment outcomes and attrition in gram-negative periprosthetic joint infection","volume":"35","author":"Kalbian","year":"2020","journal-title":"J Arthroplasty."},{"issue":"5","key":"bib25-20260730","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jinf.2022.07.009","article-title":"Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study","volume":"85","author":"Casenaz","year":"2022","journal-title":"J Infect."},{"issue":"1","key":"bib26-20260730","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis."},{"issue":"11","key":"bib27-20260730","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/imj.12902","article-title":"Antibiotic resistance: are we all doomed?","volume":"45","author":"Collignon","year":"2015","journal-title":"Intern Med J."},{"issue":"6","key":"bib28-20260730","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1302\/0301-620X.103B6.BJJ-2020-1923.R1","article-title":"Development of antibiotic resistance in periprosthetic joint infection after total knee arthroplasty","volume":"103-B","author":"Klasan","year":"2021","journal-title":"Bone Joint J."},{"issue":"1","key":"bib29-20260730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2007.01.007","article-title":"Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention","volume":"55","author":"Moran","year":"2007","journal-title":"J Infect."},{"issue":"5","key":"bib30-20260730","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/AAC.06246-11","article-title":"Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective?","volume":"56","author":"Peel","year":"2012","journal-title":"Antimicrob Agents Chemother."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.25.00541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:26:09Z","timestamp":1787750769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.25.00541"}},"subtitle":["A 24-Year Longitudinal Study"],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":30,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.25.00541","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]}}}